In the cover letter, the authors must recommend two or three potential reviewers for their article, giving their names and email addresses. Keep in mind that the editor ultimately decides whether or not to use the proposed reviewers.



We accept manuscripts submitted through the manuscript submission system, for which you must register in advance on Microbes, Infection and Chemotherapy website.


Email is the main form of correspondence between the authors and the medical journal. It is the responsibility of the corresponding author to coordinate the submission of requests for review and questions about the work under review, including, among others, questions about the integrity of the work, requests for study protocols or information of the test record, study data and documentation of institutional review, approval of the ethics committee, etc.

We recognize all the manuscripts and assign each one a unique and confidential manuscript number. We provide all authors with instructions to verify the manuscript's status via email through our manuscript management system.


Once the manuscript has been received, the editorial assistant verifies if all the established instructions were fulfilled, and if not, it will be returned to the author without entering the evaluation process. If all has been fulfilled, the manuscript is sent for the evaluation of the editors.

Each manuscript is evaluated by at least two reviewers, selected by one of the editors. The manuscripts sent for review are privileged communications and are the private property of the authors. Therefore, reviewers (such as members of the editorial team) shall not publicly discuss the work of the authors or appropriate their ideas before publishing the manuscript. Reviewers should not keep copies of revised manuscripts in their personal files and are prohibited from sharing copies of the manuscript with others. Reviewers should destroy copies of manuscripts after submitting reviews. The reviewer will receive a copy of our decision letter to the author with the comments of the other reviewers. These are also confidential.

There is no direct communication between the authors and the reviewers. The REPIS is managed under the double blind peer review system, where neither the authors nor the reviewers know the identity of the other group.


Once the reports of the reviewers are received, the general editor, together with members of the editorial committee, meet and, based on the reports of the peer reviewers, make the decision to accept the manuscript in its entirety, accept it after minor changes, determine that the article can only be accepted if major changes are made, or reject the submission.

If there is controversy regarding the decision, the editor in chief will make the final decision to accept or reject the manuscript, which will be endorsed by the editorial committee.

The correspondent author will be informed by email of any decisions taken by the editorial committee.


Authors who think that their manuscripts were erroneously rejected can email a letter of appeal to the editor who handled the manuscript. The letter should detail the author's concern and establish how the manuscript can be revised or clarified to address the key issues mentioned by the editors and reviewers. Publishers rarely reverse their original decisions. Many rejections involve priority judgments from editors that authors usually cannot address through an appeal. Once an appeal is received, the editors can confirm their decision to reject the manuscript, invite a revised manuscript or look for an additional peer review or a statistical review of the original manuscript.


With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, Microbes, Infection and Chemotherapy has decided to implement a transparent peer review process for all manuscripts submitted to the journal.

The practice will see the inclusion of a “peer review file” (a record of reviewer reports and author replies) in the footnote of the corresponding article. The peer review file will be published online (only) along with the article.


Microbes, Infection and Chemotherapy does not charge fees for sending manuscripts, or for the evaluation or publication of articles.



A proof of the article will be sent to the corresponding author. The print proof will be reviewed and possible errors will be marked, returning the revised proof within 48 hours. This proof aims to detect typographical, orthographic or form errors. Corrections that affect the content or that modify the article in its original sense will not be accepted. If corrections are not received within the deadline, the Editorial Board will not be responsible for any error or omission that may be published.

The Editorial Committee reserves the right to admit or reject the corrections made by the author in the proof.


The corresponding author of the article may consult by emailing at any time about the progress of the revision of his article or concerning any doubt that may arise.